Evidence map›Paper›PMID 34596682›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Syphilis-Naive Patients Achieve Treatment Success More Quickly: A Comparison of Time to Syphilis Treatment Success in Patients With Repeat Versus Naive Infection.

Kelika A Konda, Noah Kojima, Silver K Vargas, Gino M Calvo, Michael Reyes-Díaz, Lorenzo Giacani, Carlos F Cáceres, Jeffrey D Klausner

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Key Considerations in Evaluating Syphilis Therapeutics.Sexually transmitted diseases · 2026
    Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Kelika A KondaDivision of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.ORCID 0000-0003-2836-0174
Noah KojimaDivision of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Silver K VargasCenter for Interdisciplinary Studies in Sexuality, AIDS and Society, Universidad Peruana Cayetano Heredia, Lima, Peru.
Gino M CalvoCenter for Interdisciplinary Studies in Sexuality, AIDS and Society, Universidad Peruana Cayetano Heredia, Lima, Peru.
Michael Reyes-DíazCenter for Interdisciplinary Studies in Sexuality, AIDS and Society, Universidad Peruana Cayetano Heredia, Lima, Peru.
Lorenzo GiacaniDepartment of Medicine, Division of Allergy and Infectious Diseases, and Department of Global Health, University of Washington, Seattle, Washington, USA.
Carlos F CáceresCenter for Interdisciplinary Studies in Sexuality, AIDS and Society, Universidad Peruana Cayetano Heredia, Lima, Peru.
Jeffrey D KlausnerDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Funding

Syphilis Immunology and Biology to Improve Clinical Management and Vaccine DesignR01AI139265 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Jeffrey David Klausner · 2018 to 2026
$4.8M
NIAID NIH HHS R01 AI139265
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV InfectionsSyphilisHumansSyphilis SerodiagnosisTreatment Outcome

Identifiers

PMID34596682
PMCPMC9630857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.